Altimmune: Q1 Earnings Insights
Altimmune (NASDAQ:ALT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Altimmune beat estimated earnings by 24.14%, reporting an EPS of $-0.44 versus an estimate of $-0.58.
Revenue was down $805.52 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 11.36% increase in the share price the next day.
To track all earnings releases for Altimmune visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.